Status:
UNKNOWN
Effects of Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes
Lead Sponsor:
Assiut University
Conditions:
Patients Diagnosed as Chronic Meyloid Leukemia
Eligibility:
All Genders
18-70 years
Brief Summary
Determine the effects of tyrosine kinase Inhibitors on liver enzymes and electrolytes in relation to hematologic response in patients with chronic phase chronic meyloid leukemia.. Assiut University Ho...
Detailed Description
CML is a myeloproliferative neoplasm with unique biological and clinical features. CML accounts for 15\_20% of newly diagnosed cases of leukemias among adults. CML can present in three clinical phase...
Eligibility Criteria
Inclusion
- Newly diagnosed patients with CML
- Chronic phase CML
- Normal hepatic and renal functions
Exclusion
- Blastic phase CML
- Accelerated phase CML
- Hepatic \& renal impairment
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04326933
Start Date
January 1 2020
End Date
March 31 2022
Last Update
February 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospital
Asyut, Egypt